Amphastar Pharmaceuticals (AMPH) Long-Term Deferred Tax (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Long-Term Deferred Tax of $42.5 million for Q1 2026, down 40.3% year-over-year from $71.1 million in Q1 2025, and little changed quarter-over-quarter from $42.5 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Long-Term Deferred Tax (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Long-Term Deferred Tax history runs 14 years deep, the most recent figure standing at $42.5 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 40.3% year-over-year to $42.5 million; the TTM figure through Mar 2026 stood at $42.5 million (down 40.3% YoY), while the FY2025 annual figure was $42.5 million, down 40.3% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $42.5 million, roughly flat from $42.5 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $71.1 million in Q4 2024, with the low at $22.4 million in Q1 2022.
- The 5-year median for Long-Term Deferred Tax is $42.5 million (2025), against an average of $47.6 million.
- The sharpest annual moves came in 2023 and 2025: Long-Term Deferred Tax soared 82.45% in 2023, then tumbled 40.3% in 2025.
- Amphastar Pharmaceuticals' Long-Term Deferred Tax stood at $38.5 million in 2022, then jumped by 38.22% to $53.3 million in 2023, then soared by 33.56% to $71.1 million in 2024, then tumbled by 40.3% to $42.5 million in 2025, then changed by 0.0% to $42.5 million in 2026.
- Business Quant data shows AMPH's Long-Term Deferred Tax at $42.5 million in Q1 2026, $42.5 million in Q4 2025, and $71.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Amphastar Pharmaceuticals | 942.71 Mn | 652.59 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.46 Mn |
| Mar 31, 2026 | 42.46 Mn |
| Dec 31, 2025 | 42.46 Mn |
| Sep 30, 2025 | 71.12 Mn |
| Jun 30, 2025 | 71.12 Mn |
| Mar 31, 2025 | 71.12 Mn |
| Dec 31, 2024 | 71.12 Mn |
| Sep 30, 2024 | 53.25 Mn |
| Jun 30, 2024 | 53.25 Mn |
| Mar 31, 2024 | 53.25 Mn |
| Dec 31, 2023 | 53.25 Mn |
| Sep 30, 2023 | 40.87 Mn |
| Jun 30, 2023 | 40.87 Mn |
| Mar 31, 2023 | 38.53 Mn |
| Dec 31, 2022 | 38.53 Mn |
| Sep 30, 2022 | 22.40 Mn |
| Jun 30, 2022 | 22.40 Mn |
| Mar 31, 2022 | 22.40 Mn |
| Dec 31, 2021 | 22.40 Mn |
| Sep 30, 2021 | 22.00 Mn |